A genome-wide search for genes involved in type 2 diabetes in a recently genetically isolated population from the Netherlands

Multiple genes, interacting with the environment, contribute to the susceptibility to type 2 diabetes. We performed a genome-wide search to localize type 2 diabetes susceptibility genes in a recently genetically isolated population in the Netherlands. We identified 79 nuclear families with type 2 diabetes who were related within 13 generations and performed a 770-marker genome-wide scan search for shared founder alleles. Twenty-six markers yielded a logarithm of odds (LOD) score >0.59 (nominal P < 0.05), of which 7 reached LOD scores >1.17 (nominal P < 0.01). The strongest evidence... Mehr ...

Verfasser: Aulchenko, Y.S. (Yurii)
Vaessen, N. (Norbert)
Heutink, P. (Peter)
Pullen, J. (Jan)
Snijders, P.J.L.M. (Pieter)
Hofman, A. (Albert)
Sandkuijl, L.A. (Lodewijk)
Houwing-Duistermaat, J.J. (Jeanine)
Bennett, S. (Simon)
Oostra, B.A. (Ben)
Duijn, C.M. (Cornelia) van
Edwards, M. (Mark)
Dokumenttyp: Artikel
Erscheinungsdatum: 2003
Schlagwörter: *Genetic Screening / *Genome / Human / 0 (Genetic Markers) / Alleles / Body Mass Index / Chromosome Mapping / Chromosomes / Pair 18/genetics / Demography / Diabetes Mellitus / Type II/*genetics/pathology / Diabetes and related disorders / Founder Effect / Genes / Dominant / Genetic Markers / Genetic Predisposition to Disease/genetics / Lod Score / Middle Aged / Netherlands / Support / Non-U.S. Gov't
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29199368
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/5939

Multiple genes, interacting with the environment, contribute to the susceptibility to type 2 diabetes. We performed a genome-wide search to localize type 2 diabetes susceptibility genes in a recently genetically isolated population in the Netherlands. We identified 79 nuclear families with type 2 diabetes who were related within 13 generations and performed a 770-marker genome-wide scan search for shared founder alleles. Twenty-six markers yielded a logarithm of odds (LOD) score >0.59 (nominal P < 0.05), of which 7 reached LOD scores >1.17 (nominal P < 0.01). The strongest evidence for a type 2 diabetes locus was at marker D18S63 on chromosome 18p (LOD 2.3, P = 0.0006). This region was investigated further using additional markers. For one of these markers (D18S1105), we found a significant association with type 2 diabetes (odds ratio 6.7 [95% CI 1.5-30.7], P = 0.005 for the 97-bp allele, assuming a dominant model), which increased when limiting the analysis to patients with high BMI (12.25 [2.1-71], P = 0.003). A locus on chromosome 18p in patients with high BMI was suggested earlier by Parker et al. Our study is the first to confirm this locus.